psalexa
SearchBar Icon

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

Published Report Code Available Format Pages
 January 2017  LS10752    168

Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation

Place an order

USD 4900
USD 5900
USD 7500